These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 2491954)
21. Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. Rice JR; Spry LA; Zenser TV; Davis BB Cancer Res; 1988 Jan; 48(2):304-9. PubMed ID: 3121171 [TBL] [Abstract][Full Text] [Related]
22. Enhancing effect of allopurinol on the induction of bladder cancer in rats by n-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Wang CY; Hayashida S; Pamukcu AM; Bryan GT Cancer Res; 1976 May; 36(5):1551-5. PubMed ID: 1268818 [TBL] [Abstract][Full Text] [Related]
23. Effect of avitaminosis A and hypervitaminosis A on urinary bladder carcinogenicity of N-(4-(5-Nitro-2-furyl)-2-thiazolyl)formamide. Cohen SM; Wittenberg JF; Bryan GT Cancer Res; 1976 Jul; 36(7 PT 1):2334-9. PubMed ID: 1277139 [TBL] [Abstract][Full Text] [Related]
24. Early lesions in experimental bladder cancer: experimental design and light microscopic findings. Cohen SM; Jacobs JB; Arai M; Johansson S; Friedell GH Cancer Res; 1976 Jul; 36(7 PT 2):2508-11. PubMed ID: 1277158 [TBL] [Abstract][Full Text] [Related]
25. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts. Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786 [TBL] [Abstract][Full Text] [Related]
26. Effect of dose on the induction of urothelial proliferation by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and its relationship to bladder carcinogenesis in the rat. Hasegawa R; Cohen SM; St John M; Cano M; Ellwein LB Carcinogenesis; 1986 Apr; 7(4):633-6. PubMed ID: 3698195 [TBL] [Abstract][Full Text] [Related]
27. Long term dose response study of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced urinary bladder carcinogenesis. Arai M; St John M; Fukushima S; Friedell GH; Cohen SM Cancer Lett; 1983 Apr; 18(3):261-9. PubMed ID: 6850560 [TBL] [Abstract][Full Text] [Related]
28. Metabolism of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide by prostaglandin endoperoxide synthetase. Zenser TV; Mattammal MB; Davis BB Cancer Res; 1980 Jan; 40(1):114-8. PubMed ID: 6765914 [TBL] [Abstract][Full Text] [Related]
29. Effect of regenerative hyperplasia on the urinary bladder: carcinogenicity of sodium saccharin and N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide. Cohen SM; Murasaki G; Fukushima S; Greenfield RE Cancer Res; 1982 Jan; 42(1):65-71. PubMed ID: 7053869 [No Abstract] [Full Text] [Related]
30. Effects of sodium salts of phenobarbital and barbital on development of bladder tumors in male F344/NCr rats pretreated with either N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-nitrosobutyl-4-hydroxybutylamine. Diwan BA; Hagiwara A; Ward JM; Rice JM Toxicol Appl Pharmacol; 1989 Apr; 98(2):269-77. PubMed ID: 2711390 [TBL] [Abstract][Full Text] [Related]
32. Role of renal metabolism and excretion in 5-nitrofuran-induced uroepithelial cancer in the rat. Spry LA; Zenser TV; Cohen SM; Davis BB J Clin Invest; 1985 Sep; 76(3):1025-31. PubMed ID: 4044826 [TBL] [Abstract][Full Text] [Related]
33. Comparative effects of prostaglandin H synthase-catalyzed binding of two 5-nitrofuran urinary bladder carcinogens. Zenser TV; Palmier MO; Mattammal MB; Bolla RI; Davis BB J Pharmacol Exp Ther; 1983 Oct; 227(1):139-43. PubMed ID: 6413679 [TBL] [Abstract][Full Text] [Related]
34. NTP Toxicology and Carcinogenesis Studies of o-Nitroanisole (CAS No. 91-23-6) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1993 May; 416():1-482. PubMed ID: 12616295 [TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019 [TBL] [Abstract][Full Text] [Related]
36. Biotransformation of the bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in mice. Swaminathan S; Bryan GT Cancer Res; 1984 Jun; 44(6):2331-8. PubMed ID: 6722771 [TBL] [Abstract][Full Text] [Related]
37. The influence of antipyrene on N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced urinary tract carcinogenesis. Johansson SL; Anderström C Carcinogenesis; 1988 May; 9(5):783-7. PubMed ID: 3365839 [TBL] [Abstract][Full Text] [Related]
38. Effects of urine and continued exposure to carcinogen on progression of early neoplastic urinary bladder lesions. Rowland RG; Henneberry MO; Oyasu R; Grayhack JT Cancer Res; 1980 Dec; 40(12):4524-7. PubMed ID: 7438086 [TBL] [Abstract][Full Text] [Related]
39. NTP Toxicology and Carcinogenesis Studies of 2,2-Bis(Bromomethyl)-1,3-Propanediol (FR-1138(R)) (CAS No. 3296-90-0) in F344 Rats and B6C3F1 Mice (Feed Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 May; 452():1-465. PubMed ID: 12594523 [TBL] [Abstract][Full Text] [Related]
40. Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats. Wang CY; Kamiryo Y; Hayashida S; Croft WA Cancer Lett; 1987 Mar; 34(3):249-55. PubMed ID: 3828979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]